OK We use cookies to enhance your visit to our site and to bring you advertisements that might interest you. Read our Privacy and Cookies policies to find out more.

News Europe

In 2019, IDS will take place from 12 to 16 March. (Photograph: Koelnmesse)
0 Comments Apr 20, 2017 | News Europe

After IDS is before IDS

Post a comment by Dental Tribune International

COLOGNE, Germany: About four weeks ago, the International Dental Show (IDS) closed with record results. Overall, more than 155,000 people from over 150 countries and more than 2,300 companies from around the globe attended. The next IDS will take place from 12 to 16 March 2019. As it is never too early to prepare for the most important event in the dental calendar, Dental Tribune International (DTI) has already announced a number of dedicated products that will be offered for 2019.

For the next IDS, DTI will be publishing six issues of its today trade show newspaper in collaboration with its German partner OEMUS MEDIA. With a daily print run of 10,000 copies, the newspaper will provide attendees with the latest news from the show in English and German. In addition, today Show Preview and Review editions in English will be made available a few weeks before and after IDS, respectively.

Moreover, various newsletters, including company-specific e-newsletters and e-blasts, will be sent out several times a day to keep dentists worldwide up to date.

For the first time, DTI hosted its own lecture space at IDS 2017. As the format proved very successful, the publisher will again be providing visitors to the next IDS with the opportunity to attend live presentations by dental experts and representatives of the global dental industry.

Companies interested in publishing advertisements and press releases in DTI’s print and online media before, during and after IDS 2019 may contact their DTI sales representatives already to discuss the best options for their needs.

More information about advertising rates can be found here.

Related Content
Post a comment Print  |  Send to a friend
0 Comments
Join the Discussion
All comments are subject to approval before appearing. Submit Comment